Blood Purification
Double cascade filtration
Double cascade filtration is a two-stage plasma filtration technique that removes large proteins such as autoantibodies, immune complexes and fibrinogen while returning albumin and smaller proteins to the patient. It needs no donor plasma and sits between plasma exchange and immunoadsorption in how selective it is.

What is double cascade filtration?
Double filtration plasmapheresis (DFPP), also called double cascade filtration, is an apheresis technique that uses two membrane filters in series. The first filter separates plasma from blood cells. The second filter, with a smaller pore size, separates the plasma into a fraction containing large molecules (immunoglobulins, immune complexes, fibrinogen) and a fraction containing smaller molecules (albumin, electrolytes).
The large-molecule fraction is discarded while the small-molecule fraction is returned to the patient along with the blood cells. This selective approach eliminates the need for replacement fluids in most cases.
In how selective it is, double cascade filtration sits between therapeutic plasma exchange, which removes everything, and immunoadsorption, which removes only antibodies. It is the method of choice when several large proteins are raised at once, for example immune complexes and fibrinogen together, or when a patient needs plasma exchange but should not receive donor plasma.
How does it work?
Blood flows from the patient through the primary plasma separator, which uses centrifugal force or membrane filtration to isolate the plasma. This plasma then enters a secondary fractionation filter with a precisely calibrated pore size (typically designed to separate molecules above and below approximately 100 to 200 kDa).
Large proteins, including IgM, IgG, fibrinogen, LDL cholesterol and immune complexes, are retained and discarded. Albumin and smaller proteins pass through and are returned to the patient. This achieves targeted removal of pathological substances with minimal loss of beneficial plasma components. The pore size of the second filter can be chosen for the protein that matters: a larger pore holds back only IgM and immune complexes, a smaller one also IgG and fibrinogen. Which filter is used follows from the laboratory finding that prompted the treatment, and the same value is measured again after the course.
What conditions is it used for?
Used for chronic Lyme disease with immune complexes, autoimmune neurological disease, hyperviscosity, cryoglobulinemia and vasculitis. Not for active bleeding, unstable circulation or a severe infection; clotting values are checked before every session.
Show all indications and exclusions
- Chronic Lyme disease with elevated inflammatory markers or circulating immune complexes
- Autoimmune neurological conditions, including myasthenia gravis and CIDP
- Hyperviscosity syndrome (e.g., Waldenström's macroglobulinemia)
- Cryoglobulinemia
- Systemic vasculitis with circulating immune complexes
- Familial hypercholesterolemia
- Long COVID where fibrinogen and immune complexes are raised together and the patient should not receive donor plasma
Who it is not for: patients with active bleeding, unstable circulation, a severe infection at the time of the session, or poor venous access. Because fibrinogen is removed, clotting values are checked before every session and patients on anticoagulants are reviewed first. A physician decides on the first day.
Could this belong in your plan?
That depends on your findings, not on the therapy. Write to the International Office with a short history; it requests your records afterwards, and a physician reviews them before the video consultation and tells you whether this treatment belongs in your program.
What a session feels like
Before
A nurse places a venous line and checks your blood pressure and clotting values. You settle into a reclining chair with a book or headphones.
During
Your blood runs through the two filters and back to you. A nurse stays with you and watches your vital signs.
If you feel it
A light tingling or a moment of lightheadedness can happen; the flow is slowed until it passes.
Afterwards
You rest a short while, then walk back to your room. Feeling tired that evening is common. Your physician tells you when the next session is.
Evidence and safety
The evidence is moderate in named indications such as myasthenia gravis. Complications are uncommon, mostly tingling and mild changes in blood pressure, and clotting is checked before each session.
Show studies, risks and side effects
DFPP has been used in clinical practice since the 1980s, particularly in Japan and Europe. A 2021 review summarizes its current applications across neurology, nephrology, rheumatology and lipid disorders and the removal of large proteins with preservation of albumin (Hirano et al., 2021). The evidence is moderate in named indications: a systematic review and meta-analysis pooled studies of DFPP in myasthenia gravis (Liu et al., 2021), and a 2023 series with literature review describes its use in cryoglobulinemia (Naciri Bennani et al., 2023). The American Society for Apheresis grades the indications in its 2023 guideline (Connelly-Smith et al., 2023). For chronic Lyme disease and Long COVID the evidence is limited to the mechanism and to case series; here double cascade filtration is an individual treatment attempt, decided with the patient after medical consultation and measured before and after.
The technique has a favorable safety profile compared with standard plasma exchange because it minimizes protein loss and avoids donor plasma. Complications are uncommon and typically limited to citrate-related tingling and mild changes in blood pressure, the pattern the World Apheresis Association registry reports across apheresis procedures (Vrielink et al., 2023). Because fibrinogen falls after each session, clotting is checked before the next one.
How it fits the program
Double cascade filtration is chosen when the finding is a mixture of large proteins rather than one target. When lipids and fibrinogen dominate, H.E.L.P. apheresis is the more precise tool; when a single autoantibody dominates, immunoadsorption is. In the Lyme program the sessions run alongside antimicrobial treatment and whole-body hyperthermia; the laboratory work-up at admission names the protein, and it is measured again in week two. For patients from abroad with Long COVID or ME/CFS, the sessions are scheduled within the Long COVID and ME/CFS apheresis program, a two to three week inpatient stay with a video consultation in English before travel.
Costs depend on the number of sessions. After a physician has reviewed your findings you receive a written, itemized cost overview; what it covers and how the invoice is written is explained under costs and insurance.
Common questions about double cascade filtration
How is double cascade filtration different from plasma exchange?
Plasma exchange discards all of the plasma and replaces it with albumin or donor plasma. Double cascade filtration passes the plasma through a second filter that holds back only the large proteins and returns the rest, so in most cases nothing needs to be replaced and the risks that come with donor plasma are avoided.
Does double cascade filtration hurt?
The two venous lines are what you feel. For the 2 to 3 hours in the chair the machine runs quietly; a light tingling or a short moment of lightheadedness can occur from the anticoagulant, and the nurse slows the flow until it passes. Most patients read or sleep.
Is double cascade filtration safe?
It has been in clinical use since the 1980s and its side effects are those of apheresis in general: a drop in blood pressure, tingling, bruising at the puncture sites. Because fibrinogen is removed, clotting values are checked before each session. It is not used in patients with active bleeding or unstable circulation.
How many sessions will I need?
That depends on which protein is raised and how fast it climbs back between sessions, which the laboratory shows. A course is usually several sessions over one to two weeks. The written treatment proposal you receive before admission names the planned number.
How much does double cascade filtration cost?
The cost depends on the number of sessions. After a physician has reviewed your findings you receive a written, itemized cost overview with each session listed, so you see what the apheresis part of your program costs before anything is booked. The costs page explains how estimates and invoices are written.
Used in these departments
References
- Double filtration plasmapheresis: Review of current clinical applications. Ther Apher Dial 2021. PMID 32558286
- Cryoglobulinemia and double-filtration plasmapheresis: Personal experience and literature review. Ther Apher Dial 2023. PMID 35583180
- Efficacy and safety of double-filtration plasmapheresis treatment of myasthenia gravis: A systematic review and meta-analysis. Medicine (Baltimore) 2021. PMID 33907116
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice: The Ninth Special Issue. J Clin Apher 2023. PMID 37017433
- The world apheresis association registry, 2023 update. Transfus Apher Sci 2023. PMID 37827962
Send a free inquiry
The initial inquiry is free of charge. The International Office reviews your message and your case directly and gets back to you.
- Phone
- +49 8061 398-0
- Hours
- Mon–Thu 08:00–17:00, Fri 08:00–14:00 German time (CET/CEST); in the US Mon–Thu 2–11 a.m. ET, Fri 2–8 a.m. ET.
Munich Airport (MUC), about 60 minutes by car.